These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17593020)

  • 1. The management and outcome of chronic graft-versus-host disease.
    Fraser CJ; Scott Baker K
    Br J Haematol; 2007 Jul; 138(2):131-45. PubMed ID: 17593020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease.
    Jurado M; Vallejo C; Pérez-Simón JA; Brunet S; Ferra C; Balsalobre P; Pérez-Oteyza J; Espigado I; Romero A; Caballero D; Sierra J; Ribera JM; Díez JL
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):701-6. PubMed ID: 17531780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic graft-versus-host disease: is there an alternative to the conventional treatment?
    Gaziev D; Galimberti M; Lucarelli G; Polchi P
    Bone Marrow Transplant; 2000 Apr; 25(7):689-96. PubMed ID: 10745252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of CD20 blockade in allogeneic hematopoietic cell transplantation.
    Kharfan-Dabaja MA; Bazarbachi A
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1347-54. PubMed ID: 20083213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].
    Martínez C
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():69-71. PubMed ID: 21381292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic graft versus host disease of oral mucosa: review of available therapies.
    Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for acute graft-versus-host disease.
    Khaled Y; Reddy P; Krijanovski O
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):219-32. PubMed ID: 19519285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.
    Wolff D; Gerbitz A; Ayuk F; Kiani A; Hildebrandt GC; Vogelsang GB; Elad S; Lawitschka A; Socie G; Pavletic SZ; Holler E; Greinix H
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1611-28. PubMed ID: 20601036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects.
    Terrier B; Delmas Y; Hummel A; Presne C; Glowacki F; Knebelmann B; Combe C; Lesavre P; Maillard N; Noël LH; Patey-Mariaud de Serre N; Nusbaum S; Radford I; Buzyn A; Fakhouri F
    Nephrol Dial Transplant; 2007 May; 22(5):1369-76. PubMed ID: 17255123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal management of chronic graft-versus-host disease in children.
    Jacobsohn DA
    Br J Haematol; 2010 Aug; 150(3):278-92. PubMed ID: 20553274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Many faces of graft-versus-host disease.
    Peñas PF; Zaman S
    Australas J Dermatol; 2010 Feb; 51(1):1-10; quiz 11. PubMed ID: 20148830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft-versus-host disease: emerging concepts in prevention and therapy.
    Dean RM; Bishop MR
    Curr Hematol Rep; 2003 Jul; 2(4):287-94. PubMed ID: 12901325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral graft-versus-host disease.
    Schubert MM; Correa ME
    Dent Clin North Am; 2008 Jan; 52(1):79-109, viii-ix. PubMed ID: 18154866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Care for patients undergoing extracorporeal photopheresis to treat chronic graft-versus-host disease: review of the evidence.
    Woltz P; Castro K; Park BJ
    Clin J Oncol Nurs; 2006 Dec; 10(6):795-802. PubMed ID: 17193945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD.
    Dietrich-Ntoukas T; Cursiefen C; Westekemper H; Eberwein P; Reinhard T; Bertz H; Nepp J; Lawitschka A; Heiligenhaus A; Seitz B; Messmer EM; Meyer-ter-Vehn T; Basara N; Greinix H; Datiles MB; Lee SJ; Pavletic SZ; Wolff D
    Cornea; 2012 Mar; 31(3):299-310. PubMed ID: 22157574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the management of acute graft-versus-host disease.
    Bolaños-Meade J
    Curr Opin Oncol; 2006 Mar; 18(2):120-5. PubMed ID: 16462179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic graft-versus-host disease.
    Cutler C; Antin JH
    Curr Opin Oncol; 2006 Mar; 18(2):126-31. PubMed ID: 16462180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic graft-versus-host disease after allogeneic stem cell transplantation: challenges in prevention, science, and supportive care.
    Joseph RW; Couriel DR; Komanduri KV
    J Support Oncol; 2008; 6(8):361-72. PubMed ID: 19149321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect.
    Huang XJ; Wang Y; Liu DH; Xu LP; Liu KY; Chen H; Chen YH; Han W; Shi HX
    Bone Marrow Transplant; 2009 Sep; 44(5):309-16. PubMed ID: 19234512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.